4142.TW Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (3 Jun 2024 @ 01:30):

Stats
Today's Volume	592 012
Average Volume	896 718
Market Cap	11.88B
EPS	TWD-0.436 ( 2024-05-16 )
Next earnings date	( TWD0 ) 2024-08-10
Last Dividend	TWD0 ( N/A )
Next Dividend	TWD0 ( N/A )
P/E	-20.18
ATR14	TWD0.0250 (0.09%)

Volume Correlation

Long: 0.05 (neutral)

Short: 0.58 (weak)

Signal:(68.056) Neutral

Adimmune Corporation Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Adimmune Corporation Correlation - Currency/Commodity

0.46
( neutral )

0.39
( neutral )

0.00
( neutral )

0.52
( weak )

-0.20
( neutral )

Adimmune Corporation Financials

Annual	2023
Revenue:	TWD1.79B
Gross Profit:	TWD410.94M (23.02 %)
EPS:	TWD-1.830

FY	2023
Revenue:	TWD1.79B
Gross Profit:	TWD410.94M (23.02 %)
EPS:	TWD-1.830

FY	2022
Revenue:	TWD2.25B
Gross Profit:	TWD891.08M (39.58 %)
EPS:	TWD0.340

FY	2021
Revenue:	TWD1.64B
Gross Profit:	TWD464.15M (28.28 %)
EPS:	TWD0.110

Financial Reports:

No articles found.

Adimmune Corporation Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Adimmune Corporation

Adimmune Corporation manufactures and sells human vaccines in Taiwan. It offers AdimFlu-S, a quadrivalent influenza vaccine; tetanus toxoid alum precipitated product that is used for the prevention of tetanus after injury; Japanese encephalitis vaccines; Trivalent influenza vaccines; Quadrivalent influenza vaccine; Influenza A (H1N1) Virus Monovalent Vaccine; Tetanus Toxoid; and purified Tuberculin, as well as contract manufacturing services. The company was formerly known as Kuo Kwang Serum and Vaccine Manufacture Co., Ltd. and changed its name to Adimmune Corporation in 2001. Adimmune Corporation was founded in 1965 and is headquartered in Taichung, Taiwan.